Edward Kim
Chief Tech/Sci/R&D Officer chez OREXO AB
Profil
Edward Kim is currently the Chief Medical Officer at Orexo AB since 2022.
Prior to this, he worked as the Vice Chairman-Clinical Services at Robert Wood Johnson Medical School and as the Vice President & Head-Medical Affairs at Biohaven Pharmaceutical Holding Co. Ltd.
Dr. Kim completed his undergraduate degree at Harvard University and his doctorate at Sidney Kimmel Medical College.
Postes actifs de Edward Kim
| Sociétés | Poste | Début |
|---|---|---|
| OREXO AB | Chief Tech/Sci/R&D Officer | 26/10/2022 |
Anciens postes connus de Edward Kim
| Sociétés | Poste | Fin |
|---|---|---|
| Robert Wood Johnson Medical School | Corporate Officer/Principal | - |
| BIOHAVEN PHARMACEUTICAL HOLDING COMPANY LTD. | Corporate Officer/Principal | - |
Formation de Edward Kim
| Harvard University | Undergraduate Degree |
| Sidney Kimmel Medical College | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| OREXO AB | Health Technology |
| Entreprise privées | 1 |
|---|---|
Biohaven Pharmaceutical Holding Co. Ltd.
 Biohaven Pharmaceutical Holding Co. Ltd. Pharmaceuticals: MajorHealth Technology Biohaven Pharmaceutical Holding Co. Ltd. is a clinical-stage biopharmaceutical company, which engages in the research and development of late-stage product candidates targeting neurological diseases, including rare disorders. It focuses on a pipeline of product candidates that represent mechanistic platforms, calcitonin gene-related peptide receptor antagonists, and glutamate modulators. The company was founded in September 2013 and is headquartered in New Haven, CT. | Health Technology |
